Drug Profile
Ethinylestradiol/chlormadinone - Grunenthal
Alternative Names: Balianca; Belara; GRT4248Latest Information Update: 15 Jun 2023
Price :
$50
*
At a glance
- Originator Grunenthal
- Class Alkylated estrogenic steroids; Chlorinated steroids; Hormonal contraceptives; Hormonal replacements; Norpregnatrienes; Oral contraceptives
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Pregnancy
- No development reported Acne
Most Recent Events
- 23 May 2023 Grunenthal and Gedeon Richter entered into a market licensee to commercialize ethinylestradiol/chlormadinone for Pregnancy (Prevention) in Brazil
- 05 Nov 2008 Grunenthal and FAES Farma agree to co-promote ethinylestradiol/chlormadinone in Spain for Contraception/Pregnancy (Prevention)
- 13 Dec 2007 The Committee for Medicinal Products for Human Use recommends refusal of ethinylestradiol/chlormadinone for acne in women in the EU